| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.43▲ | 5.40▲ | 5.40▲ | 5.37▼ | 5.35▼ |
| MA10 | 5.50▼ | 5.53▼ | 5.53▼ | 5.59▼ | 4.92▲ |
| MA20 | 5.81▼ | 5.89▼ | 5.85▼ | 5.47▼ | 3.99▲ |
| MA50 | 6.12▼ | 5.70▼ | 5.53▼ | 4.62▲ | 4.24▲ |
| MA100 | 5.83▼ | 5.05▲ | 4.96▲ | 3.78▲ | 6.40▼ |
| MA200 | 5.08▲ | 5.09▲ | 4.54▲ | 4.02▲ | 24.07▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.033▼ | -0.089▼ | -0.089▼ | -0.090▼ | 0.249▲ |
| RSI | 40.256▼ | 44.948▼ | 47.183▼ | 50.173▲ | 57.259▲ |
| STOCH | 30.159 | 21.230 | 21.165 | 21.898 | 37.304 |
| WILL %R | -78.846▼ | -80.531▼ | -80.870▼ | -75.720▼ | -63.073 |
| CCI | -38.075 | -52.239 | -52.294 | -52.914 | 51.557 |
|
Wednesday, July 09, 2025 04:15 AM
Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent Office Notice of Allowance for a new patent on its lead product, GIMOTI.
|
|
Thursday, March 13, 2025 08:09 PM
Evoke Pharma Inc (EVOK) nearly doubles its annual revenue, reduces net loss, and outlines ambitious growth strategies for 2025.
|
|
Thursday, March 13, 2025 01:30 PM
EVOKE PHARMA Hedge Fund Activity We have seen 0 institutional investors add shares of EVOKE PHARMA stock to their portfolio, and 7 decrease their positions in their most recent quarter.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/09/25 | 5.36 | 5.36 | 5.03 | 5.20 | 18,179 |
| 29/08/25 | 5.39 | 5.57 | 5.272 | 5.45 | 46,068 |
| 28/08/25 | 5.10 | 5.389 | 5.10 | 5.29 | 24,706 |
| 27/08/25 | 5.22 | 5.62 | 5.21 | 5.49 | 49,963 |
| 26/08/25 | 5.27 | 5.70 | 5.05 | 5.41 | 397,561 |
| 25/08/25 | 5.03 | 5.3117 | 4.98 | 5.20 | 71,228 |
| 22/08/25 | 5.65 | 5.8328 | 5.50 | 5.53 | 162,009 |
| 21/08/25 | 6.52 | 7.04 | 6.00 | 6.34 | 7,553,679 |
| 20/08/25 | 5.75 | 5.96 | 5.5825 | 5.83 | 21,717 |
| 19/08/25 | 5.84 | 6.17 | 5.5543 | 6.13 | 59,561 |
|
|
||||
|
|
||||
|
|